Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/751
Title: | FLT3-ITD positive acute myeloid leukemia: A retrospective analysis of the role of allogeneic transplant and allelic ratio in patient management | Authors: | Ellis, M. Irving, I. Marlton, P. Clarey, J. Baveshi, K. Cochrane, T. Morris, K. Taylor, E. Kennedy, G. |
Issue Date: | 2018 | Source: | Asia-Pacific journal of clinical oncology Jan 31 , 2018 | Journal Title: | Asia-Pacific journal of clinical oncology | Journal: | Asia Pac J Clin Oncol | Abstract: | AIM: FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) positive AML is associated with increased relapse risk and reduced overall survival (OS) compared to non-FLT3-mutated AML. The aim of this study was to evaluate the impact of allelic ratio and allogeneic transplant on outcomes in FLT3-ITD+ AML. METHODS: A retrospective study across five centers in Queensland, Australia, was conducted to examine survival outcomes and impact of FLT3-ITD allelic ratio and allograft. RESULTS: Seventy-one patients were included in the study. OS was significantly better for patients who were able to be allografted in first complete remission (CR1; 50.1 months vs 8.5 months; P = 0.0002). We did not find allelic ratio to be predictive of outcome. CONCLUSION: Transplantation in first complete remission is associated with improved outcomes for patients with FLT3+ AML. When feasible transplantation in CR1 is recommended. We do not currently recommend using allelic ratio to stratify risk unless this has been validated by local results.1743-7563Taylor, Emma | DOI: | 10.1111/ajco.12827 | Keywords: | AmlStem cell transplantation;hematology;leukemias | Type: | Article |
Appears in Sites: | Gold Coast Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.